Contemporary practice patterns in the management of newly diagnosed hypertension

CMAJ. Canadian Medical Association Journal

Volumn 157, Issue 1, 1997, Pages 23-30

  McAlister, Finlay A ^a,c   Teo, Koon K ^a   Lewanczuk, Richard Z ^b   Wells, George ^b   Montague, Terrence J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM ION; SODIUM ION; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG CONTRAINDICATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT REFERRAL; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SODIUM URINE LEVEL; URINALYSIS;

EID: 0030791719     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Detsky AS. Regional variation in medical care. N Engl J Mid 1995;333:589-90.
2. Blumenthal D. The variation phenomenon in 1994. N Engl J Med 1994;331: 1017-8.
3. Ribacke AI. Treatment preferences, return visit planning and factors affecting hypertension practice amongst general practitioners and internal medicine specialists (The General Practitioner Hypertension Practice Study). J Intern Med 1995;237:473-8.
4. Weiland SK, Keil U, Speisberg A, Hense AIW, Hartel U, Gefeller O, et al. Diagnosis and management of hypertension by physicians in the Federal Republic of Germany. JHypertms 1991;9:131-4.
5. Fotherby AID, Harper GD, Potter JF. General practitioners' management of hypertension in elderly patients. BMJ 1992;305:750-2.
6. Steven ID, Wilson DH, Wakefield A1A, BeilbyJ, Coffey GA, Esterman AJ, et al. South Australian hypertension survey. General practitioner experiences wi th drug treatment. A led J Aust 1992;156:641-4.
7. Manolio TA, Cutler JA, Furberg CD, Psaty BAI, Whelton PK, Applegate WB. Trends in pharmacologie management of hypertension in the United States. Ant Intern Med 1995;155:829-37.
8. Kofron PAI, Rastam L, Pine P, Holder W, Luepker RV. Phpician practice for cardiovascular disease risk-factor reduction in six upper Alidwestern communities. J FamPract 1991;32:49-55.
9. Epstein AAI, Hartely RAI, Charlton JR, Harris CM, Jarman B, AIcNeil BJ. A comparison of ambulatory test ordering for hypertensive patients in the United States and England. JAMA 1984;252:1723-7.
10. Cloher TP, Whelton PK. Phpician approach to the recognition and initial management of hypertension. Results of a statewide survey of Alaryland physicians. Arch Intern Mid 1986;146:529-33.
11. Fortmann SP, Sallis JF, Alagnus PAI, Farquhar JW. Attitudes and practices of physicians regarding hypertension and smoking: the Stanford Five City Project. Prev Med 1985;14:70-80.
12. Kawachi I, Alalcolm LA, Purdie G. Variability in antihypertensive drug therapy in general practice:results from a random national survey. N Z Med J 1989;102:307-9.
13. Steven ID, Wilson DH, Wakefield AIA, Beilby J, Coffey GA, Esterman AJ, et al. Soudi Australian hypertension survey. General practitioner knowledge and reported management practices -a cause for concern? MedJAust 1992;156:423-8.
14. Troein AI, Arneson T, Rastam L, Pirie PL, Seiander S, Luepker RV. Reported treatment of hypertension by family physicians in Sweden and Alinnesota: a physician survey of practice habits. J Intern Med 1995;238:215-21.
15. Ribacke AI. The concept of individualized hypertension care in general practice and outpatient clinics. The general practitioner hypertension practice study (III). ScandJPrim Health Care l995;11(2):112-7.
16. Wilhelmsen L, Strasser T. WHO-WHL Hypertension Alanagement Audit Project. J Hum Hypertens 1993;7(3):257-63.
17. Psaty BAI, Savage PJ, Tell GS, PolakJF, Hirsch CH, Gardin JAI, et al. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA 1993; 270:1837-41.
18. Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AAI, et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995;155:1855-60.
19. Jerome AI, Xakellis GC, Angstman G, Patchin W. Initial medication selection for treatment of hypertension in an open-panel HAIO. J Am Board Fam Pract 1995;8:l-6.
20. Johannesson AI, Borgquist L, Jonsson B, Rastam L. The costs of treating hypertension: an analysis of different cut-off points. Health Polity 1991;18:141-50.
21. Aloser AI. Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Intern Mid 1994;154:1665-72.
22. Stevens RD, Bingley LJ Jr, Boger AI, El-Wanni J, Kasten J. Variability in the management of hypertension and cost-effectiveness: methodology, community care results, and potential cost reductions. Sue Set Med 1984;18(9):767-74.
23. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. Can Med Assoc J 1993;149:289-93.
24. Haynes RB, Lacourcière Y, Rabkin SW, Leenen FHH, Logan AG, Wright N, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. Can Med Asm J 1993;149:409-18.
25. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, Alyers MG. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologie treatment of essential hypertension. Can Med Assoc J 1993; 149:575-84.
26. Reeves RA, Fodor JG, Gryfe CI, Patterson C, Spence JD. Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. Can Med Asm J 1993;149:815-20.
27. Dawson KG, AIcKenzie JK, Ross SA, Chiasson JL, Hamet P. Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. Can Med Assoc J 1993;149:821-6.
28. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-83.
29. Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P. The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press 1993;2:86-100.
30. Gifford RW, Kirkendall W, O'Connor DT, Weidman W. Office evaluation of hypertension: a statement for health professionals by a writing group of the Council for High Blood Pressure Research, American Heart Association. Hypertension 1989;13:283-93.
31. Chockalingham A, Abbott D, Bass AI, Battista R, Cameron R, de Champlain J, et al. Recommendations of the Canadian Consensus Conference on Nonpharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23,1989, Halifax, Nova Scotia. Can Med Assoc J 1990;142:1397-409.
32. Joffres MR, Titanich KLC, Hessel PA. The Alberta Heart Health Survey: methods and results. CanJCardal 1993;9:300-8.
33. Hartley RM, Charlton JR, Harris CM, Jannan B. Patterns of physicians' use of medical resources in ambulatory settings. Am J Public Health 1987;77:565-67.
34. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol 1995;76:570-3.
35. Burnum JF. Medical practice a la mode: how medical fashions determine medical care. N Engl J Med 1987;317:1220-2.
36. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathon TE, Weiss NS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies.JAMA 1995;274:620-5.
37. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993;270:713-22.
38. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis RD, Kochar MS, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. NEngl J Med 1993;328:914-21.
39. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypertens 1996;9:413-8.
40. Collins R, Peto R, MacMahon S, Hebert P, Fiebich NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
41. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407-13.
42. McDonald CJ. Medical heuristics: the silent adjudicators of clinical practice. Ann Intern Med 1996;I24:56-62.
43. Grimshaw JAI, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
44. Lomas J, Anderson GA1, Domnick-Pierre K, Vayda E, Enkin AIW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-11.
45. Alontague T, Taylor L, Alartin S, Bames At, Ackman AI, Tsuyuki R, et al. Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. Can J Cardiol 1995;11:487-92.